Translational utility of experimental autoimmune encephalomyelitis: recent developments.
Andre Ortlieb Guerreiro-Cacais1, Hannes Laaksonen1, Sevasti Flytzani1
1Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Journal of Inflammation Research
|December 2, 2015
Summary
This review explores how genetic findings from genome-wide association studies (GWAS) relate to experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis (MS). Understanding these genetic pathways in EAE could lead to personalized MS treatments.
Area of Science:
- Neuroimmunology
- Genetics
- Autoimmune Diseases
Background:
- Multiple sclerosis (MS) is a complex autoimmune disease with known genetic and environmental factors.
- Genome-wide association studies (GWAS) have identified numerous genetic polymorphisms linked to MS.
- The functional significance of these polymorphisms and their role in disease mechanisms require further elucidation.
Purpose of the Study:
- To review research on experimental autoimmune encephalomyelitis (EAE), the animal model for MS, from a GWAS perspective.
- To highlight studies investigating the role of GWAS-identified genes and pathways in EAE pathogenesis.
- To explore how understanding these pathways can aid in stratifying MS subphenotypes and developing personalized treatments.
Main Methods:
- Literature review focusing on GWAS findings in the context of EAE research.
- Analysis of studies examining the contribution of specific GWAS genes and their associated pathways to EAE.
- Synthesis of information regarding the translational potential of EAE research for MS.
Main Results:
- GWAS have identified numerous genetic loci associated with MS risk.
- Research in EAE models has begun to explore the functional roles of these GWAS-identified genes and pathways in autoimmune neuroinflammation.
- Specific pathways implicated by GWAS are being investigated for their contribution to EAE pathogenesis.
Conclusions:
- Connecting GWAS findings to EAE pathogenesis provides insights into MS mechanisms.
- Identifying the role of specific genetic pathways in EAE can help in understanding disease heterogeneity.
- This approach may facilitate the development of targeted and individualized therapeutic strategies for multiple sclerosis.


